Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.76 USD | +0.09% | +0.93% | -7.33% |
Apr. 30 | North American Morning Briefing : More Earnings -2- | DJ |
Apr. 29 | Axsome Therapeutics Phase 3 Alzheimer's Treatment Trial is High Risk, High Reward, Morgan Stanley Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.33% | 3.5B | |
-4.04% | 87.17B | |
+2.76% | 40.1B | |
-16.98% | 31.38B | |
+57.86% | 25.12B | |
-16.24% | 15.59B | |
-9.12% | 12B | |
-42.56% | 11.8B | |
-17.10% | 11.8B | |
+6.89% | 8.81B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Baird Initiates Axsome Therapeutics With Outperform Rating, Price Target is $108